| Revenue growth | Value |
|---|---|
| 1Y (TTM) | +54% |
| 3Y CAGR | -8% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | +825% |
| 3Y CAGR | -40% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
PfizerPFIZER | ₹4,622.40 -5.20 (0.11%) | 21,168.16 | 28.79 | 5.04 | ||
Caplin Point LaboratoriesCAPLIPOINT | ₹2,852.10 +131.60 (4.84%) | 20,634.90 | 30.43 | 5.75 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹6,870.00 +2.00 (0.03%) | 17,175.63 | 101.26 | 19.68 | ||
Natco PharmaNATCOPHARM | ₹837.60 -5.65 (0.67%) | 15,100.75 | 13.19 | 1.64 |